Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like ...

Q25 – – $32.0 million Revuforj® (revumenib) net revenue; total Revuforj prescriptions in 3Q25 increased 25% over 2Q25, highlighting strong demand – – $45.8 million Niktimvo™ (axatilimab-csfr) net ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January ...

Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core businessRaising OJEMDA ...

Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like ...

According to the latest statistics from the Ministry of Data and Statistics, 21.9% of cancer-related deaths are attributed to ...